Measurement of free and total sialic acid by isotopic dilution liquid chromatography tandem mass spectrometry method

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 31, 2011, Pages 3694-3699

  Tebani, Abdellah ^a   Schlemmer, Dimitri ^a   Imbard, Apolline ^a   Rigal, Odile ^a   Porquet, Dominique ^a   Benoist, Jean François ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

N Acetylneuraminic Acid; Sialic acid storage disease; Tandem mass spectrometry

Indexed keywords

BIOLOGICAL FLUIDS; CALIBRATION CURVES; DERIVATIZATIONS; ELECTROSPRAY SOURCE; INTERNAL STANDARDS; IONIZATION MODES; ISOTOPIC DILUTION; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MULTIPLE REACTIONS MONITORING; N-ACETYLNEURAMINIC ACID; N-BUTANOL; PERITONEAL FLUID; REVERSE PHASE; SELECTIVE DETECTION; SIALIC ACIDS; STORAGE DISORDERS; TANDEM MASS SPECTROMETRY; TOTAL SIALIC ACIDS; URINE SAMPLE;

BODY FLUIDS; CHROMATOGRAPHY; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY;

CARBOXYLIC ACIDS;

BUTANOL; SIALIC ACID;

ACCURACY; ARTICLE; DERIVATIZATION; ELECTROSPRAY MASS SPECTROMETRY; INBORN ERROR OF METABOLISM; ISOTOPE DILUTION ASSAY; MOLECULAR STABILITY; MONITORING; MULTIPLE REACTION MONITORING; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCREENING; SENSITIVITY AND SPECIFICITY; STANDARD; TANDEM MASS SPECTROMETRY; URINALYSIS; URINE LEVEL;

CARBON ISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; CREATININE; DRUG STABILITY; HUMANS; LEAST-SQUARES ANALYSIS; N-ACETYLNEURAMINIC ACID; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIALIC ACID STORAGE DISEASE; TANDEM MASS SPECTROMETRY;

EID: 82955162703     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.10.009     Document Type: Article

References (27)

1. Wang B., Brand-Miller J. Eur. J. Clin. Nutr. 2003, 57(11):1351.
2. Pertti Aula W.A.G. The Metabolic and Molecular Bases of Inherited Diseases 2001, 5109. B.A. Scriver, C.R. Sly, W.S.D. Valle (Eds.).
3. Aminoff D. Biochem. J. 1961, 81:384.
4. Svennerholm L. Biochim. Biophys. Acta 1957, 24(3):604.
5. Svennerholm E., Svennerholm L. Scand. J. Clin. Lab. Invest. 1958, 10(1):97.
6. Aminoff D., et al. Anal. Biochem. 1980, 101(1):44.
7. Warren L. J. Biol. Chem. 1959, 234(8):1971.
8. Crook M., Haq M., Tutt P. Clin. Biochem. 1993, 26(6):449.
9. Matsuno K., Suzuki S. Anal. Biochem. 2008, 375(1):53.
10. Hammond K.S., Papermaster D.S. Anal. Biochem. 1976, 74(2):292.
11. Sugawara Y., et al. Anal. Biochem. 1983, 132(1):147.
12. Teshima S., et al. Clin. Chem. 1988, 34(11):2291.
13. Siskos P.A., Spyridaki M.H. J. Chromatogr. B: Biomed. Sci. Appl. 1999, 724(2):205.
14. Makatsori E., et al. J. Chromatogr. B: Biomed. Sci. Appl. 1998, 712(1-2):23.
15. Hara S., et al. Anal. Biochem. 1987, 164(1):138.
16. Ogawa H.K., et al. J. Chromatogr. 1993, 612(1):145.
17. Lagana A., et al. Anal. Biochem. 1993, 215(2):266.
18. Fritsch M., Geilen C.C., Reutter W. J. Chromatogr. A 1996, 727(2):223.
19. Anumula K.R. Anal. Biochem. 1995, 230(1):24.
20. Shaw C.J., Chao H., Xiao B. J. Chromatogr. A 2001, 913(1-2):365.
21. Varki N.M., Varki A. Lab. Invest. 2007, 87(9):851.
22. van der Ham M., et al. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 848(2):251.
23. Valianpour F., et al. Clin. Chem. 2004, 50(2):403.
24. Hashii N., et al. J. Chromatogr. A 2007, 1160(1-2):263.
25. van der Ham M., et al. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2010, 878(15-16):1098.
26. Food and Drug Administration, C.f.D.E.a.R.C. FDA Guidance for Industry, Bioanalytical Method Validation (2001). [cited] Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
27. Allevi P., Femia E.A., Costa M.L., Cazzola R., Anastasia M. J. Chromatogr. A 2008, 1212:98.